Pathogenetic Justification of the Use of 5-Alpha Reductase Inhibitors in the Treatment of Benign Prostatic Hyperplasia

    September 2022 in “ Experimental and Сlinical Urology ”
    О. В. Золотухин, A.V. Esin, Yu.Yu. Madykin
    Studysummary This review examines the use of 5-alpha-reductase inhibitors for treating benign prostatic hyperplasia, noting moderate positive effects without complete cure and the need for further research to understand drug mechanisms and pathogenesis.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on ecuro.ru →
    Discuss this study in the Community →

    Research cited in this study 6

    1. The Connection of 5-Alpha Reductase Inhibitors to the Development of Depression Biomedicine & Pharmacotherapy · 2021
    2. Androgenetic Alopecia and Coronavirus Infection Consilium medicum · 2021
    3. Three-Dimensional Proteome-Wide Scale Screening for the 5-Alpha Reductase Inhibitor Finasteride: Identification of a Novel Off-Target Journal of Medicinal Chemistry · 2021
    4. Post-Finasteride Syndrome: Our Current Knowledge Vestnik urologii · 2020
    5. Efficacy and Safety of Finasteride Monotherapy in Patients with Benign Prostatic Hyperplasia: A Critical Review of the Literature Archivio Italiano di Urologia e Andrologia · 2020
    6. Post-Finasteride Syndrome: An Emerging Clinical Problem Neurobiology of Stress · 2019

    Related research 5

    1. Change in Hair Growth-Related Gene Expression Profile in Human Isolated Hair Follicles Induced by 5-Alpha Reductase Inhibitors – Dutasteride and Finasteride – in the Presence of Testosterone Singapore Medical Journal · 2021
    2. 5-Alpha Reductase Inhibitors in Androgenetic Alopecia: Shifting Paradigms, Current Concepts, Comparative Efficacy, and Safety Dermatologic Therapy · 2020
    3. What Do We Know About 5-Alpha Reductase Inhibitors? Surgical and Cosmetic Dermatology · 2018
    4. Atypical Post-Finasteride Syndrome: A Pharmacological Riddle Indian Journal of Pharmacology · 2016
    5. 5 Alpha-Reductase Inhibitors: What's New? Current opinion in urology · 2003